Recall Enforment Report D-1347-2015
Recall Details
Multi event Drug Recall Enforcement Report Class II voluntary initiated by Wockhardt Usa Inc., originally initiated on 07-29-2015 for the product Lisinopril Tablets USP, 20 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, UPC 3 64679 94106 5, NDC 64679-941-06. The product was recalled due to cgmp deviations: an fda inspection identified inadequate investigations of past market complaints.. The product was distributed nationwide and the recall is currently terminated.
Recall Enforcement Reports
Recall Number | Recall Initiation Date | Report Date | Recall Classification | Quantity | Product Description | Recall Reason | Status |
---|---|---|---|---|---|---|---|
D-1347-2015 | 07-29-2015 | 08-26-2015 | Class II | 3378 bottles | Lisinopril Tablets USP, 20 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, UPC 3 64679 94106 5, NDC 64679-941-06. | CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints. | Terminated |
D-1346-2015 | 07-29-2015 | 08-26-2015 | Class II | 1704 bottles | Lisinopril Tablets USP, 5 mg, 1000-count bottles, Rx Only, Manufactured by: Wockhardt Limited, Mumbai, India; Distributed by: Wockhardt USA LLC, 20 Waterview Blvd, Parsippany, NJ 07054 USA, UPC 3 64679 92806 6, NDC 64679-928-06. | CGMP Deviations: An FDA inspection identified inadequate investigations of past market complaints. | Terminated |